GSK says EU pharma legislation overhaul could trigger investment shiftBusiness, TherapeuticsBritish drugmaker GSK on Wednesday warned that the overhaul of laws governing the EU’s pharmaceuticals industry risks forcing companies to invest and innovate elsewhere, which would hurt EU efforts to improve access to medicines. Read more April 26, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/02/GSK-pauses-trial-of-respiratory-virus-vaccine-in-pregnant-women-Reuters-2-18-22.jpg 381 728 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-04-26 05:57:322023-04-26 11:41:59GSK says EU pharma legislation overhaul could trigger investment shift